FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382394911> ?p ?o ?g. }

• W4382394911 abstract "Introduction : Post-ICU admission cumulative positive fluid balance (PFB) is associated with increased mortality among critically ill patients. We sought to test whether this risk varied across biomarker-based risk strata upon adjusting for illness severity, presence of severe acute kidney injury (AKI), and use of renal replacement therapy (CRRT) in pediatric septic shock. Design : Ongoing multi-center prospective observational cohort. Setting : Thirteen pediatric ICUs in the United States (2003-2023). Patients : Six hundred and eighty-one children with septic shock. Interventions : None. Measurements and Main Results : Cumulative percent positive fluid balance between day 1-7 (Day 1-7%PFB) was determined. Primary outcome of interest was complicated course defined as death or persistence of ≥ 2 organ dysfunctions by day 7. PERSEVERE-II biomarkers were used to assign mortality probability and categorize patients into high (n = 91), intermediate (n = 134), and low (n = 456) mortality risk strata. Cox proportional hazard regression models with adjustment for PERSEVERE-II mortality probability, presence of sepsis associated acute kidney injury (SA-AKI) on Day 3, and any use of CRRT, demonstrated that time-dependent variable Day 1-7%PFB was independently associated with increased hazard of complicated course in the cohort. Risk stratified analyses revealed that each 10% increase in Day 1-7%PFB was independently associated with increased hazard of complicated course among patients with high mortality risk strata (adj HR of 1.24 (95%CI: 1.08-1.42), p = 0.002), but not among those categorized as intermediate- or low- mortality risk. Conclusions : Our data demonstrate the independent influence of cumulative %PFB on the risk of complicated course. Contrary to our previous report, this risk was largely driven by patients categorized as having a high-mortality risk based on PERSEVERE-II biomarkers. Further research is necessary to determine whether this subset of patients may benefit from targeted deployment of restrictive fluid management or early initiation of de-escalation therapies upon resolution of shock." @default.
• W4382394911 created "2023-06-29" @default.
• W4382394911 creator A5002239589 @default.
• W4382394911 creator A5012594790 @default.
• W4382394911 creator A5020675273 @default.
• W4382394911 creator A5022979690 @default.
• W4382394911 creator A5026529892 @default.
• W4382394911 creator A5031540879 @default.
• W4382394911 creator A5046881277 @default.
• W4382394911 creator A5048932268 @default.
• W4382394911 creator A5059370580 @default.
• W4382394911 creator A5061785145 @default.
• W4382394911 creator A5066184403 @default.
• W4382394911 creator A5069821127 @default.
• W4382394911 creator A5071300729 @default.
• W4382394911 creator A5072207917 @default.
• W4382394911 creator A5079982654 @default.
• W4382394911 creator A5082112042 @default.
• W4382394911 creator A5084387470 @default.
• W4382394911 creator A5088663182 @default.
• W4382394911 date "2023-06-28" @default.
• W4382394911 modified "2023-10-16" @default.
• W4382394911 title "Revisiting post-ICU admission fluid balance across pediatric sepsis mortality risk strata: A secondary analyses from a prospective observational cohort study." @default.
• W4382394911 cites W2034180131 @default.
• W4382394911 cites W2054938569 @default.
• W4382394911 cites W2069289706 @default.
• W4382394911 cites W2076590961 @default.
• W4382394911 cites W2171062872 @default.
• W4382394911 cites W2330359983 @default.
• W4382394911 cites W2473327107 @default.
• W4382394911 cites W2514264936 @default.
• W4382394911 cites W2531389434 @default.
• W4382394911 cites W2560147359 @default.
• W4382394911 cites W2581605534 @default.
• W4382394911 cites W2904677804 @default.
• W4382394911 cites W2946302516 @default.
• W4382394911 cites W2985953291 @default.
• W4382394911 cites W2998853022 @default.
• W4382394911 cites W2999530114 @default.
• W4382394911 cites W3008170328 @default.
• W4382394911 cites W3090489412 @default.
• W4382394911 cites W3178541157 @default.
• W4382394911 cites W3182332828 @default.
• W4382394911 cites W4214811416 @default.
• W4382394911 cites W4283011822 @default.
• W4382394911 cites W4285043325 @default.
• W4382394911 cites W4308187208 @default.
• W4382394911 cites W4321606574 @default.
• W4382394911 doi "https://doi.org/10.21203/rs.3.rs-3117188/v1" @default.
• W4382394911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37461591" @default.
• W4382394911 hasPublicationYear "2023" @default.
• W4382394911 type Work @default.
• W4382394911 citedByCount "0" @default.
• W4382394911 crossrefType "posted-content" @default.
• W4382394911 hasAuthorship W4382394911A5002239589 @default.
• W4382394911 hasAuthorship W4382394911A5012594790 @default.
• W4382394911 hasAuthorship W4382394911A5020675273 @default.
• W4382394911 hasAuthorship W4382394911A5022979690 @default.
• W4382394911 hasAuthorship W4382394911A5026529892 @default.
• W4382394911 hasAuthorship W4382394911A5031540879 @default.
• W4382394911 hasAuthorship W4382394911A5046881277 @default.
• W4382394911 hasAuthorship W4382394911A5048932268 @default.
• W4382394911 hasAuthorship W4382394911A5059370580 @default.
• W4382394911 hasAuthorship W4382394911A5061785145 @default.
• W4382394911 hasAuthorship W4382394911A5066184403 @default.
• W4382394911 hasAuthorship W4382394911A5069821127 @default.
• W4382394911 hasAuthorship W4382394911A5071300729 @default.
• W4382394911 hasAuthorship W4382394911A5072207917 @default.
• W4382394911 hasAuthorship W4382394911A5079982654 @default.
• W4382394911 hasAuthorship W4382394911A5082112042 @default.
• W4382394911 hasAuthorship W4382394911A5084387470 @default.
• W4382394911 hasAuthorship W4382394911A5088663182 @default.
• W4382394911 hasBestOaLocation W43823949111 @default.
• W4382394911 hasConcept C126322002 @default.
• W4382394911 hasConcept C177713679 @default.
• W4382394911 hasConcept C188816634 @default.
• W4382394911 hasConcept C201903717 @default.
• W4382394911 hasConcept C207103383 @default.
• W4382394911 hasConcept C2777628635 @default.
• W4382394911 hasConcept C2777984932 @default.
• W4382394911 hasConcept C2778384902 @default.
• W4382394911 hasConcept C2779541074 @default.
• W4382394911 hasConcept C2780472472 @default.
• W4382394911 hasConcept C44249647 @default.
• W4382394911 hasConcept C50382708 @default.
• W4382394911 hasConcept C71924100 @default.
• W4382394911 hasConcept C72563966 @default.
• W4382394911 hasConceptScore W4382394911C126322002 @default.
• W4382394911 hasConceptScore W4382394911C177713679 @default.
• W4382394911 hasConceptScore W4382394911C188816634 @default.
• W4382394911 hasConceptScore W4382394911C201903717 @default.
• W4382394911 hasConceptScore W4382394911C207103383 @default.
• W4382394911 hasConceptScore W4382394911C2777628635 @default.
• W4382394911 hasConceptScore W4382394911C2777984932 @default.
• W4382394911 hasConceptScore W4382394911C2778384902 @default.
• W4382394911 hasConceptScore W4382394911C2779541074 @default.
• W4382394911 hasConceptScore W4382394911C2780472472 @default.
• W4382394911 hasConceptScore W4382394911C44249647 @default.
• W4382394911 hasConceptScore W4382394911C50382708 @default.
• W4382394911 hasConceptScore W4382394911C71924100 @default.

• next